|
|||||
|
|
Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopecia |
|
| Authors: | S. Cedirian MD F. Bruni MD F. Quadrelli MD G. Caro MD M. Fortuna MD PhD A. Rossi MD PhD B. M. Piraccini MD PhD M. Starace MD PhD |
| Affiliation: | 1. Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy;2. Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy;3. Dermatology Unit, Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy |
| Abstract: | Hair loss may change the quality of life since modern society considers hair an essential element in beauty definition. The most common causes of hair loss are androgenetic alopecia (AGA) and telogen effluvium (TE). AGA requires a lifetime use of minoxidil or finasteride (and sometimes they lose efficacy over the years), whereas TE has no standardized therapy available. Our study focuses on a novel topical regenerative preparation that, by mimicking autologous PRP, can safely and efficiently improve hair loss in patients affected by TE and AGA. |
| Keywords: | androgenetic alopecia growth factors hair loss PRP telogen effluvium |